DE3705055C2 - - Google Patents

Info

Publication number
DE3705055C2
DE3705055C2 DE19873705055 DE3705055A DE3705055C2 DE 3705055 C2 DE3705055 C2 DE 3705055C2 DE 19873705055 DE19873705055 DE 19873705055 DE 3705055 A DE3705055 A DE 3705055A DE 3705055 C2 DE3705055 C2 DE 3705055C2
Authority
DE
Germany
Prior art keywords
coronary
fluoro
pressure
methylphenylimino
imidazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE19873705055
Other languages
German (de)
English (en)
Other versions
DE3705055A1 (de
Inventor
Werner Dr. 6538 Muenster-Sarmsheim De Traunecker
Alexander Dr. 6507 Ingelheim De Walland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Priority to DE19873705055 priority Critical patent/DE3705055A1/de
Publication of DE3705055A1 publication Critical patent/DE3705055A1/de
Application granted granted Critical
Publication of DE3705055C2 publication Critical patent/DE3705055C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19873705055 1987-02-18 1987-02-18 Verwendung von 2-(3-fluor-4-methylphenylimino)-imidazolidin zur behandlung der koronaren herzkrankheit Granted DE3705055A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19873705055 DE3705055A1 (de) 1987-02-18 1987-02-18 Verwendung von 2-(3-fluor-4-methylphenylimino)-imidazolidin zur behandlung der koronaren herzkrankheit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873705055 DE3705055A1 (de) 1987-02-18 1987-02-18 Verwendung von 2-(3-fluor-4-methylphenylimino)-imidazolidin zur behandlung der koronaren herzkrankheit

Publications (2)

Publication Number Publication Date
DE3705055A1 DE3705055A1 (de) 1988-09-01
DE3705055C2 true DE3705055C2 (el) 1990-12-06

Family

ID=6321199

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19873705055 Granted DE3705055A1 (de) 1987-02-18 1987-02-18 Verwendung von 2-(3-fluor-4-methylphenylimino)-imidazolidin zur behandlung der koronaren herzkrankheit

Country Status (1)

Country Link
DE (1) DE3705055A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form

Also Published As

Publication number Publication date
DE3705055A1 (de) 1988-09-01

Similar Documents

Publication Publication Date Title
DE69722401T2 (de) Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods
DE69632743T2 (de) Verfahren zur regulierung des vagaltonus
EP0185210B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten
DE3012862A1 (de) Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel
DE69110779T2 (de) Schilddrüsenhormone zur kardialen behandlung.
EP0363671B1 (de) Verwendung von ACE-Inhibitoren gegen Neointimabildung nach Gefässverletzung
DE3705055C2 (el)
EP0471388B1 (de) Mittel zur Behandlung der Herzinsuffizienz
EP0132595B1 (de) Tokolytisches Mittel
DE2833964A1 (de) Verfahren zur steigerung der kontraktionsfaehigkeit des herzmuskels
DE2743704C2 (de) L- oder DL-Phenylglycine enthaltende Arzneimittel
DE3880564T2 (de) Arzneimittel zur behandlung von herzinsuffizienz.
EP0005732B1 (de) Verwendung von 2-Amino-oxazolo- oder 2-Amino-thiazolo-[5,4-d]azepinen sowie deren Säureadditionssalzen zur Herstellung eines Arzneimittels für die Verwendung bei der Bekämpfung von Angina Pectoris
DE2131679A1 (de) 3,4,5-Trimethoxybenzamidocarbonsaeure und ihre Salze sowie Arzneipraeparate
DE2755016C2 (el)
EP0524512B1 (de) Antihypertensive Kombination
WO2004082680A1 (de) Pramipexol zur reduzierung übermässiger nahrungsaufnahme bei kindern
DE2207460C2 (de) Verwendung von Hydroxycylohexylaminderivaten bei der Behandlung von ödematös atelektatischen Lungenveränderungen
DE3136455C2 (de) Verwendung von Caerulein oder dessen pharmazeutisch verträglichen Salzen bei der Bekämpfung von psychotischen Krankheitszuständen
DE3410218A1 (de) Tergurid als antihypertensivum
DE1617336C2 (de) Arzneimittel gegen Angina pectoris
DD283931A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von herzrhythmusstoerungen
DE60016038T2 (de) Neue verwendung von levosimendan
DE3880579T2 (de) Pharmazeutische zusammensetzungen zur behandlung der verstopfung der luftwege.
AT360536B (de) Verfahren zur herstellung des neuen salpeter- saeureesters von n-(2-hydroxyaethyl)nicotinamid und von dessen salzen

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee